SCHEMBL5028027

SCHEMBL5028027

FC(F)(F)C1CCc2ccccc2C1

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.50
PNMT P11086 1/20 0.44
ANPEP P15144 1/20 0.43
GRIN2B Q13224 3/20 0.40
MTNR1A P48039 3/20 0.40
MTNR1B P49286 3/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
HTR1A P08908 1/20 0.40
CYP19A1 P11511 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19393068 0.79 PLAU (0.50) PLAUANPEPGRIN2BMTNR1AMTNR1B
SCHEMBL14815575 0.76 ANPEP (0.49) PLAUANPEPGRIN2BMTNR1AMTNR1B
SCHEMBL14039949 0.76 OPRK1 (0.34) PNMT
SCHEMBL31197411 0.74 DRD2 (0.48) GRIN2BCYP19A1
SCHEMBL25900511 0.73 PLAU (0.44) PLAUANPEPGRIN2BMTNR1AMTNR1B
SCHEMBL29080091 0.71 PLAU (0.56) PLAUANPEPGRIN2BMTNR1AMTNR1B
SCHEMBL17151026 0.71 PLAU (0.56) PLAUANPEPGRIN2BMTNR1AMTNR1B
SCHEMBL10062425 0.71 PLAU (0.46) PLAUANPEPGRIN2BMTNR1AMTNR1B
SCHEMBL28185295 0.71 CYP1A2 (0.45) PNMTANPEPCYP19A1MAOA
SCHEMBL4443332 0.71 PLAU (0.46) PLAUPNMTANPEPGRIN2BMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118496196-A Preparation method of alpha-trifluoromethyl aryl ketone compound 嘉兴职业技术学院 2024-08-16 CN disclosed
WO-2015040424-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AND THEIR USE AS PYRUVATE DEHYDROGENASE KINASE INHIBITORS VERNALIS (R&D) LIMITED (GB) 2015-03-26 WO disclosed
EP-2450358-A1 Fused, tricyclic sulfonamide inhibitors of gamma secretase Elan Pharmaceuticals Inc. (US) 2012-05-09 EP disclosed
EP-1274700-A1 DIHYDROBENZOPYRANS, DIHYDROBENZOTHIOPYRANS, AND TETRAHYDROQUINOLINES FOR THE TREATMENT OF COX-2-MEDIATED DISORDERS Pharmacia Corporation (US) 2003-01-15 EP disclosed
WO-2001049675-A1 DIHYDROBENZOPYRANS, DIHYDROBENZOTHIOPYRANS, AND TETRAHYDROQUINOLINES FOR THE TREATMENT OF COX-2-MEDIATED DISORDERS PHARMACIA CORPORATION (US) 2001-07-12 WO disclosed